ClinicalTrials.Veeva

Menu

Ultra Low Dose CT for CACS and AC of SPECT

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Coronary Artery Disease

Treatments

Device: Standard dose non-contrast enhanced CT
Device: Ultra low dose non-contrast enhanced CT

Study type

Interventional

Funder types

Other

Identifiers

NCT02458352
USZ-2015-0072

Details and patient eligibility

About

The aim of the study is to compare the CACS obtained from standard dose CT to the CACS obtained from ultra-low-dose scans. Additionally, the usefulness of ultra-low-dose CT for AC of myocardial perfusion SPECT will be assessed.

Enrollment

105 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients referred for myocardial perfusion SPECT
  • Male and Female subjects ≥18 years of age,
  • Written informed consent

Exclusion criteria

  • Pregnancy or breast-feeding
  • CACS of 0 after inclusion of 10 patients with CACS 0
  • Stents or implanted cardiac devices (valves, pace makers, ICD)
  • Coronary artery bypass grafts

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

105 participants in 1 patient group

Standard dose CT, Ultra-low dose CT
Other group
Description:
Standard dose non-contrast enhanced CT (clinically indicated) and Ultra low dose non-contrast enhanced CT (as part of the trial)
Treatment:
Device: Standard dose non-contrast enhanced CT
Device: Ultra low dose non-contrast enhanced CT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems